- Home
- SBH vs AVXL Comparison
SBH vs AVXL Comparison
Compare SBH & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- AVXL
- Stock Information
- Founded
- SBH 1964
- AVXL 2001
- Country
- SBH United States
- AVXL United States
- Employees
- SBH N/A
- AVXL N/A
- Industry
- SBH Other Specialty Stores
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBH Consumer Discretionary
- AVXL Health Care
- Exchange
- SBH Nasdaq
- AVXL Nasdaq
- Market Cap
- SBH 940.7M
- AVXL 779.5M
- IPO Year
- SBH 2006
- AVXL N/A
- Fundamental
- Price
- SBH $8.94
- AVXL $8.35
- Analyst Decision
- SBH Buy
- AVXL Strong Buy
- Analyst Count
- SBH 6
- AVXL 2
- Target Price
- SBH $12.70
- AVXL $44.00
- AVG Volume (30 Days)
- SBH 2.7M
- AVXL 1.0M
- Earning Date
- SBH 02-13-2025
- AVXL 02-12-2025
- Dividend Yield
- SBH N/A
- AVXL N/A
- EPS Growth
- SBH 4.93
- AVXL N/A
- EPS
- SBH 1.66
- AVXL N/A
- Revenue
- SBH $3,723,624,000.00
- AVXL N/A
- Revenue This Year
- SBH $0.99
- AVXL N/A
- Revenue Next Year
- SBH $1.73
- AVXL N/A
- P/E Ratio
- SBH $5.39
- AVXL N/A
- Revenue Growth
- SBH 0.57
- AVXL N/A
- 52 Week Low
- SBH $8.88
- AVXL $3.25
- 52 Week High
- SBH $14.79
- AVXL $14.44
- Technical
- Relative Strength Index (RSI)
- SBH 29.99
- AVXL 40.39
- Support Level
- SBH $9.03
- AVXL $8.50
- Resistance Level
- SBH $9.67
- AVXL $9.20
- Average True Range (ATR)
- SBH 0.51
- AVXL 0.49
- MACD
- SBH -0.07
- AVXL -0.01
- Stochastic Oscillator
- SBH 2.91
- AVXL 32.23
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.